about
Gene expression profiling of patient-derived pancreatic cancer xenografts predicts sensitivity to the BET bromodomain inhibitor JQ1: implications for individualized medicine effortsFactors released by the tumor far microenvironment are decisive for pancreatic adenocarcinoma development and progression.Speeding towards individualized treatment for pancreatic cancer by taking an alternative road.BTN3A is a prognosis marker and a promising target for Vγ9Vδ2 T cells based-immunotherapy in pancreatic ductal adenocarcinoma (PDAC).Epigenetics of gastrointestinal diseases: notes from a workshopPrognostic significance of circulating PD-1, PD-L1, pan-BTN3As, BTN3A1 and BTLA in patients with pancreatic adenocarcinomaDesigning and repurposing drugs to target intrinsically disordered proteins for cancer treatment: using NUPR1 as a paradigmTargeting intrinsically disordered proteins involved in cancerFlavonoid-alkylphospholipid conjugates elicit dual inhibition of cancer cell growth and lipid accumulationAurora kinase B-phosphorylated HP1α functions in chromosomal instability
P50
Q37733990-0EBA3A04-4EC8-4C1E-951E-C00C788B3DAFQ47393374-ED3CEAF7-6787-45D6-8152-AAE2060BE18DQ47924304-60CCA55B-577A-4C81-BF47-69C01481129FQ50420977-C39A1036-3BC2-490E-B77D-19E66B92CFC2Q57179338-2C8A4F21-EC71-49B8-B2AA-5685FA09F27DQ64268803-148B7081-859B-48A5-A135-C9D2CC12E7BAQ90138449-CC0F3D3B-C903-4276-9C6B-F7485C18362DQ91018401-8FDE4058-6AC8-4C5B-94E9-7065BB5E1F6AQ91595815-C5B8C525-0A12-4984-901F-EA3A4CCB3517Q92301817-9496DB80-3682-4880-84D6-EDBBA3EE7E47
P50
description
researcher
@en
wetenschapper
@nl
name
Juan Iovanna
@en
Juan Iovanna
@nl
type
label
Juan Iovanna
@en
Juan Iovanna
@nl
prefLabel
Juan Iovanna
@en
Juan Iovanna
@nl
P31
P496
0000-0003-1822-2237